Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2024 Oct 11;80(Pt 11):1165–1169. doi: 10.1107/S2056989024009733

Synthesis, crystal structure and absolute configuration of (3aS,4R,5S,7aR)-7-(but-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetra­hydro-2H-1,3-benzodioxole-4,5-diol

Alejandro Peixoto de Abreu Lima a,*, Enrique Pandolfi a, Valeria Schapiro a, Leopoldo Suescun b
Editor: F F Ferreirac
PMCID: PMC11660465  PMID: 39712156

The crystal structure of the title compound was solved to confirm the relative absolute configuration of the chiral centers.

Keywords: speciosins, epoxide opening, chiral bicycle, crystal structure

Abstract

The absolute configuration of the title compound, C13H16O4, determined as 1S,2R,3S,4R based on the synthetic pathway, was confirmed by single-crystal X-ray diffraction. The mol­ecule is a relevant inter­mediary for the synthesis of speciosins, ep­oxy­quinoides or their analogues. The mol­ecule contains fused five- and six-membered rings with two free hydroxyl groups and two protected as an iso­propyl­idenedioxo ring. The packing is directed by hydrogen bonds that define double planes of mol­ecules laying along the ab plane and van der Waals inter­actions between aliphatic chains that point outwards of the planes.

1. Chemical context

Speciosins are a group of ep­oxy­quinoids isolated from fungal origins that exhibit diverse biological activities (Jiang et al., 2009, 2011; Kim et al., 2006). So far, only one racemic synthesis has been reported (Hookins et al., 2011). We proposed the first synthetic enanti­oselective approach towards speciosins starting from halodiols obtained from halo­benzene (Vila et al., 2013). In our reported enanti­oselective route for the synthesis of speciosin A, we obtained mol­ecule 1 in two steps in 65% yield from the diol A (Fig. 1). Compound 1 had to be epoxidized in order to functionalize the most substituted double bond (Peixoto de Abreu Lima et al., 2019). That reaction yielded epoxides 2 and 3, a pair of regioisomers. Despite our efforts, we could not obtain the desired regioselectivity towards 2, and we obtained a mixture of 2 and 3 using a wide variety of solvents, temperature, and concentration (Fig. 2). Another problem we faced was the separation of 2 and 3, which obliged us to continue our synthetic route using the mixture of both epoxides. Treating 2 and 3 under basic conditions we obtained the products of tosyl­ate elimination and epoxide basic opening for each regioisomer (Fig. 3). Diols 4 and 5 could be successfully separated by column chromatography. Compound 4 is a valuable inter­mediate for the synthesis of speciosin A. On the other hand, 5 may be useful as an inter­mediate for the synthesis of other ep­oxy­quinoides like harveynone or its analogues (Pandolfi et al., 2013; Nagata et al., 1992), especially given that it could easily be obtained in higher proportions (Peixoto de Abreu Lima et al., 2019). The epoxide opening in basic aqueous conditions can yield two diastereomers depending on which carbon is attacked by the hydroxyl, though it is expected that the allylic position is more reactive. Thus, it is important to confirm the stereochemistry of the formed diol before continuing with further synthetic steps by means of crystallization and crystal structure determination.1.

Figure 1.

Figure 1

Biotransformation of bromo­benzene and alkyne side chain introduction via Sonogashira coupling.

Figure 2.

Figure 2

Epoxidation of mol­ecule 1.

Figure 3.

Figure 3

Epoxide opening in basic aqueous conditions.

2. Structural commentary

Fig. 4 shows the structure of 5 (the title compound) as determined by single-crystal X-ray diffraction. All bond distances and angles fall within the expected values for this kind of organic mol­ecule. The absolute configuration, determined as 1S,2R,3S,4R based on the synthetic pathway, was confirmed by X-ray diffraction on the basis of anomalous dispersion of light atoms only. The cyclo­hexene core of the mol­ecule shows puckering angles (Cremer & Pople, 1975) of Θ = 61.0 (7)° and Φ = 51.7 (8)°, indicating a conformation between envelope (Θ = 54.7°, Φ = 60°) and screw-boat (Θ = 67.5°, Φ = 30°) with C2 forming the flap. The planar part of the C1–C6–C5–C4–C3 ring (fit of the plane with an r.m.s. deviation of 0.0405 Å) forms a dihedral angle of 52.5 (3)° with the flap (C1–C2–C3). The linear buten-3-en-1-ynyl chain is coplanar with the main part of the ring with a maximum deviation from the plane of 0.21 Å for C10 (see supporting information). The five-membered iso­propyl­idenedioxo ring (O3–C3–C4–O4–C11) is also envelope-shaped with Φ2 = 289.1 (10)° (idealized Φ2 = 288°) with O4 forming the flap. The absolute configuration of the four chiral centers and the double bond allows for the five substituents of the cyclo­hexene ring to be equatorial (O1, O2, C7) or bis­ectional (O3, O4) with three of the five H atoms being in axial positions.

Figure 4.

Figure 4

ORTEP view of the title compound showing the numbering scheme. Ellipsoids are drawn at the 30% probability level.

3. Supra­molecular features

In the crystal, mol­ecules are connected through strong O—H⋯O hydrogen bonds (see Table 1 and Fig. 5). Pairs of O2—H2A⋯O3i hydrogen bonds connect mol­ecules related by a twofold rotation along [010]. O1—H1 groups pointing outwards from the axis form infinite O1—H1⋯O1ii chains along [010] between twofold-screw-rotated equivalent mol­ecules [symmetry codes: (i) Inline graphic − x, y − Inline graphic, 1 − z; (ii) 1 − x, y, 1 − z] as shown in Fig. 6. The combination of both hydrogen bonds provides a strong set of inter­molecular inter­actions that define planes parallel to the ac plane with the but-3-en-1-ynyl chains pointing outwards on both sides. Weak van der Waals inter­actions connect these planes along [001] as shown in Fig. 7.

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
O1—H1⋯O1i 0.82 2.00 2.803 (3) 167
O2—H2A⋯O3ii 0.82 2.19 2.995 (6) 168

Symmetry codes: (i) Inline graphic; (ii) Inline graphic.

Figure 5.

Figure 5

Unit-cell contents of 5. Note that two hydrogen bonds involving O2 and O3 connect twofold-rotation-related mol­ecules, and a third one connects screw-rotation-related mol­ecules.

Figure 6.

Figure 6

View of the unit cell along the [101] direction showing linear chains of mol­ecules connected through O1—H1⋯O1 hydrogen bonds.

Figure 7.

Figure 7

View of the unit cell along [010] direction showing the weak inter­actions between aliphatic chains in parallel hydrogen-bonded mol­ecular planes of 5.

4. Database survey

One dozen entries in the 2024.1 version of the CSD (Groom et al., 2016) are related to the title compound sharing a mono-substituted tetra­hydroxy-cyclo­hexene core. The most inter­esting ones are discussed hereafter. The asymmetric unit of TEDZUA (Buckler et al., 2017) contains two independent mol­ecules that only differ from 5 in the substituent at C5 sharing the same absolute structure at all the chiral centers and the iso­propyl­idenedioxo ring containing O3 and O4. The cyclo­hexene cores show an almost perfect envelope conformation in both mol­ecules, but the shape of the bulky vanillin substituent affects the conformation of the five-membered ring and the positions of O4 substituents of C4 in each mol­ecule making them axial. The packing is directed by π-stacking between vanillin residues and a more complex hydrogen-bond network including one crystallization water mol­ecule. RAQLED (Taher et al., 2017) is a tetra­hydroxy-cyclo­hexene with a –Csp–Csp– chain at C5 (ending in a substituted benzene ring) but the hydroxyl groups at C3 and C4 are free (not part of a five-membered ring) and C2 has an inverted absolute configuration making the cyclo­hexene ring fall between an envelope and a half-chair conformation with two of the OH substituents on C4 and C1 in axial positions. The packing is similar to that of 5 with a complex hydrogen-bond network defining planes of mol­ecules with the non-polar substituents pointing outwards, inter­acting weakly with parallel planes. RURVEH (Macías et al., 2015) and HOYFIN (Tibhe et al., 2018) show a tetra­hydroxy-cyclo­hexene core with inverted configurations at C1 and C2 with respect to 5. The ring conformations fall between envelope and half-chair with the flap at the opposite side of the ring plane, keeping both OH substituents close to equatorial positions. RURVEH also shares the iso­propyl­idenedioxo ring including O3 and O4 with 5. The packing in HOYFIN is directed by a complex 3D hydrogen-bond network while two different inter­molecular hydrogen bonds define the packing of RURVEH, but in this case linear chains of hydrogen-bonded mol­ecules are observed with weak inter­actions between parallel chains.

5. Synthesis and crystallization

The synthesis of the title compound was carried out through a mixture of epoxides 2 and 3. The epoxides (400 mg; 1.00 mmol, ratio 2:3 5:1) were dissolved in tetra­hydro­furan (40 mL) at room temperature and a solution of potassium hydroxide 10% mV (40 mL) was added (Fig. 3). The mixture was refluxed for 4 h. After completion of the reaction, the mixture was diluted with 50 mL of ethyl acetate. The aqueous fraction was neutralized with 10% HCl and extracted with ethyl acetate (portions of 20 mL) until no further products were seen on the aqueous phase on TLC. The combined ethereal fractions were dried with Na2SO4 and filtered. Concentration of the filtrate, followed by column chromatography (hexa­nes:ethyl acetate 7:3) yielded 4 (177 mg; 81%) and 5 (33 mg; 15%). Small, plate-shaped crystals suitable for X-ray structure analysis were obtained by dissolving 5 in MeOH and slowly evaporating the solvent at room temperature, (m.p.) dec. 435 K. HRMS: C13H16O4+Na calc:259.0946; exp : 259.0953. [α]25.5589nm = −13.10° (0.32 g/100 mL of MeOH). 1H NMR (400 MHz, CDCl3) δ (ppm): 6.18 (d, J = 2.1 Hz, 1H), 5.94 (dd, J = 17.6, 11.2 Hz, 1H), 5.71 (dd, J = 17.6, 2.0 Hz, 1H), 5.54 (dd, J = 11.2, 2.1 Hz, 1H), 4.61 (d, J = 6.4 Hz, 1H), 4.18 (d, J = 8.5 Hz, 1H), 4.12 (dd, J = 8.7, 6.3 Hz, 1H), 3.66 (t, J = 8.5 Hz, 1H), 2.90 (br s, 2H), 1.54 (s, 3H), 1.43 (s, 3H). 13C NMR (101 MHz, CDCl3) δ (ppm): 138.6, 128.0, 119.2, 117.0, 111.1, 89.3, 87.3, 77.4, 74.6, 74.2, 70.4, 28.3, 26.1.

6. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2. All C and O atoms in the structure were refined anisotropically with restraints applied to the thermal ellipsoids of C9 and C10 and their bond distance that appeared shorter than expected due to significant librational disorder of the final atoms of the chain. Neither C9 nor C10 were split due to the lack of clear alternative positions. All H atoms were located in difference ΔF maps and refined freely in the initial model to confirm the absolute structure of the chiral centers. In the final model they were modeled in geometrically suitable positions and refined as riding with Uiso=1.2/1.5Ueq of the core/terminal parent atom.

Table 2. Experimental details.

Crystal data
Chemical formula C13H16O4
M r 236.26
Crystal system, space group Monoclinic, C2
Temperature (K) 296
a, b, c (Å) 17.4126 (13), 5.0996 (4), 14.9856 (11)
β (°) 109.652 (2)
V3) 1253.17 (16)
Z 4
Radiation type Cu Kα
μ (mm−1) 0.77
Crystal size (mm) 0.38 × 0.26 × 0.12
 
Data collection
Diffractometer Bruker D8 Venture/Photon 100 CMOS
Absorption correction Multi-scan (SADABS; Krause et al., 2015)
Tmin, Tmax 0.646, 0.754
No. of measured, independent and observed [I > 2σ(I)] reflections 10420, 2628, 2138
R int 0.049
(sin θ/λ)max−1) 0.642
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.080, 0.248, 1.13
No. of reflections 2628
No. of parameters 157
No. of restraints 3
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.41, −0.21
Absolute structure Flack x determined using 752 quotients [(I+)−(I)]/[(I+)+(I)] (Parsons et al., 2013)
Absolute structure parameter 0.1 (4)

Computer programs: APEX3 and SAINT (Bruker, 2018), OLEX2.solve (Bourhis et al., 2015, Dolomanov et al., 2009), SHELXL2019/2 (Sheldrick, 2015) and ShelXle (Hübschle et al., 2011).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989024009733/ee2008sup1.cif

e-80-01165-sup1.cif (320.1KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989024009733/ee2008Isup2.hkl

e-80-01165-Isup2.hkl (210.4KB, hkl)
e-80-01165-Isup3.cml (5.2KB, cml)

Supporting information file. DOI: 10.1107/S2056989024009733/ee2008Isup3.cml

CCDC reference: 2389407

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

The authors wish to thank ANII (EQC_2012_07), CSIC and Facultad de Química-UdelaR for funds to purchase the diffractometer and the financial support of OPCW and PEDECIBA. AP also thanks ANII (POS_NAC_2014_1_102803) and CAP for postgraduate scholarships.

supplementary crystallographic information

(3aS,4R,5S,7aR)-7-(But-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-2H-1,3-benzodioxole-4,5-diol . Crystal data

C13H16O4 F(000) = 504
Mr = 236.26 Dx = 1.252 Mg m3
Monoclinic, C2 Cu Kα radiation, λ = 1.54178 Å
a = 17.4126 (13) Å Cell parameters from 7392 reflections
b = 5.0996 (4) Å θ = 5.2–77.8°
c = 14.9856 (11) Å µ = 0.77 mm1
β = 109.652 (2)° T = 296 K
V = 1253.17 (16) Å3 Plate, colourless
Z = 4 0.38 × 0.26 × 0.12 mm

(3aS,4R,5S,7aR)-7-(But-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-2H-1,3-benzodioxole-4,5-diol . Data collection

Bruker D8 Venture/Photon 100 CMOS diffractometer 2628 independent reflections
Radiation source: Cu Incoatec microsource 2138 reflections with I > 2σ(I)
Detector resolution: 10.4167 pixels mm-1 Rint = 0.049
\j and ω scans θmax = 81.6°, θmin = 5.3°
Absorption correction: multi-scan (SADABS; Krause et al., 2015) h = −22→22
Tmin = 0.646, Tmax = 0.754 k = −6→6
10420 measured reflections l = −18→19

(3aS,4R,5S,7aR)-7-(But-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-2H-1,3-benzodioxole-4,5-diol . Refinement

Refinement on F2 Hydrogen site location: inferred from neighbouring sites
Least-squares matrix: full H-atom parameters constrained
R[F2 > 2σ(F2)] = 0.080 w = 1/[σ2(Fo2) + (0.1316P)2 + 0.6357P] where P = (Fo2 + 2Fc2)/3
wR(F2) = 0.248 (Δ/σ)max < 0.001
S = 1.13 Δρmax = 0.41 e Å3
2628 reflections Δρmin = −0.21 e Å3
157 parameters Absolute structure: Flack x determined using 752 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
3 restraints Absolute structure parameter: 0.1 (4)

(3aS,4R,5S,7aR)-7-(But-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-2H-1,3-benzodioxole-4,5-diol . Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.Least-squares planes (x,y,z in crystal coordinates) and deviations from them (* indicates atom used to define plane) 7.1271 (0.0500) x + 3.5828 (0.0094) y + 6.1525 (0.0364) z = 4.8815 (0.0081) * -0.0395 (0.0049) C1 * 0.0862 (0.0063) C2 * -0.0383 (0.0049) C4 * -0.0247 (0.0051) C5 * 0.0316 (0.0054) C6 * 0.0183 (0.0075) C7 * -0.0331 (0.0100) C8 * -0.1482 (0.0159) C9 * 0.1478 (0.0145) C10 0.7181 (0.0077) C3 1.0769 (0.0080) O1 0.9312 (0.0104) O2 0.6098 (0.0104) O3 0.5627 (0.0104) O4 Rms deviation of fitted atoms = 0.0798 6.7576 (0.0357) x + 3.6373 (0.0092) y + 6.2811 (0.0338) z = 4.8211 (0.0091) Angle to previous plane (with approximate esd) = 1.364 ( 0.435 ) * -0.0646 (0.0036) C1 * 0.0457 (0.0028) C2 * -0.0264 (0.0029) C4 * 0.0026 (0.0042) C5 * 0.0427 (0.0038) C6 0.6990 (0.0071) C3 0.0448 (0.0094) C7 0.0054 (0.0126) C8 -0.0921 (0.0258) C9 0.2316 (0.0289) C10 1.0394 (0.0069) O1 0.8638 (0.0074) O2 0.5755 (0.0096) O3 0.5959 (0.0094) O4 Rms deviation of fitted atoms = 0.0419 - 1.1053 (0.0796) x - 4.9917 (0.0065) y + 3.0656 (0.0891) z = 0.2849 (0.0528) Angle to previous plane (with approximate esd) = 52.465 ( 0.318 ) * 0.0000 (0.0000) C2 * 0.0000 (0.0000) C3 * 0.0000 (0.0000) C4 Rms deviation of fitted atoms = 0.0000

(3aS,4R,5S,7aR)-7-(But-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-2H-1,3-benzodioxole-4,5-diol . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
C2 0.3746 (3) 0.1116 (12) 0.4110 (3) 0.0683 (11)
H2 0.398970 0.279483 0.437829 0.082*
C1 0.2844 (3) 0.1188 (12) 0.3889 (4) 0.0709 (12)
H1A 0.261212 −0.053188 0.365494 0.085*
O1 0.2645 (3) 0.1853 (10) 0.4702 (3) 0.0957 (14)
H1 0.252857 0.051859 0.493396 0.144*
O3 0.47692 (19) 0.0935 (9) 0.3375 (3) 0.0779 (11)
O4 0.4120 (2) 0.4298 (8) 0.2405 (3) 0.0750 (10)
C3 0.3927 (3) 0.0527 (10) 0.3215 (3) 0.0635 (11)
H3 0.377713 −0.128755 0.301629 0.076*
C4 0.3504 (3) 0.2420 (11) 0.2399 (3) 0.0661 (11)
H4 0.333731 0.145670 0.179805 0.079*
C5 0.2776 (3) 0.3908 (12) 0.2485 (4) 0.0714 (12)
O2 0.4080 (3) −0.0979 (11) 0.4766 (3) 0.0939 (13)
H2A 0.433176 −0.036444 0.528898 0.141*
C6 0.2469 (3) 0.3234 (12) 0.3150 (5) 0.0791 (15)
H6 0.199730 0.407119 0.315916 0.095*
C7 0.2395 (3) 0.5872 (13) 0.1767 (4) 0.0790 (14)
C8 0.2085 (4) 0.7380 (16) 0.1167 (5) 0.0968 (19)
C9 0.1732 (7) 0.918 (2) 0.0403 (7) 0.139 (4)
H9 0.190917 0.900463 −0.011464 0.167*
C10 0.1213 (9) 1.096 (3) 0.0339 (11) 0.197 (7)
H10A 0.101128 1.123418 0.083313 0.295*
H10B 0.103243 1.200024 −0.020116 0.295*
C11 0.4859 (3) 0.2806 (12) 0.2714 (4) 0.0750 (14)
C12 0.5552 (4) 0.4617 (17) 0.3208 (8) 0.119 (3)
H12A 0.562490 0.585508 0.276005 0.179*
H12B 0.604292 0.361554 0.347503 0.179*
H12C 0.543123 0.553832 0.370311 0.179*
C13 0.5005 (5) 0.131 (2) 0.1907 (5) 0.113 (3)
H13A 0.459372 −0.001682 0.167864 0.170*
H13B 0.553287 0.049946 0.213143 0.170*
H13C 0.497907 0.250061 0.140183 0.170*

(3aS,4R,5S,7aR)-7-(But-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-2H-1,3-benzodioxole-4,5-diol . Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
C2 0.064 (2) 0.073 (3) 0.070 (2) −0.002 (2) 0.024 (2) 0.004 (2)
C1 0.064 (3) 0.072 (3) 0.085 (3) −0.001 (2) 0.037 (2) 0.002 (3)
O1 0.113 (3) 0.091 (3) 0.109 (3) −0.006 (3) 0.071 (3) −0.009 (2)
O3 0.0525 (16) 0.093 (3) 0.090 (2) 0.0072 (17) 0.0260 (15) 0.016 (2)
O4 0.0591 (17) 0.073 (2) 0.100 (2) 0.0048 (16) 0.0359 (16) 0.0134 (19)
C3 0.054 (2) 0.064 (3) 0.074 (3) 0.0032 (19) 0.0240 (19) 0.001 (2)
C4 0.058 (2) 0.069 (3) 0.071 (2) −0.001 (2) 0.0226 (19) 0.000 (2)
C5 0.057 (2) 0.072 (3) 0.084 (3) 0.005 (2) 0.023 (2) 0.004 (3)
O2 0.102 (3) 0.099 (3) 0.076 (2) 0.009 (3) 0.0231 (19) 0.018 (2)
C6 0.058 (2) 0.077 (3) 0.109 (4) −0.001 (2) 0.037 (3) 0.003 (3)
C7 0.068 (3) 0.079 (3) 0.087 (3) −0.005 (3) 0.021 (2) −0.004 (3)
C8 0.078 (4) 0.098 (4) 0.103 (4) −0.003 (4) 0.015 (3) 0.010 (4)
C9 0.158 (9) 0.114 (7) 0.116 (6) −0.019 (6) 0.008 (6) 0.016 (6)
C10 0.196 (13) 0.124 (9) 0.219 (14) 0.009 (9) 0.002 (10) 0.057 (11)
C11 0.063 (3) 0.075 (3) 0.096 (3) 0.002 (2) 0.038 (2) 0.008 (3)
C12 0.069 (3) 0.086 (5) 0.183 (8) −0.008 (3) 0.016 (4) 0.008 (5)
C13 0.111 (5) 0.138 (6) 0.111 (5) 0.035 (5) 0.064 (4) 0.007 (5)

(3aS,4R,5S,7aR)-7-(But-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-2H-1,3-benzodioxole-4,5-diol . Geometric parameters (Å, º)

C2—O2 1.437 (7) C5—C7 1.457 (8)
C2—C1 1.492 (6) O2—H2A 0.8200
C2—C3 1.508 (7) C6—H6 0.9300
C2—H2 0.9800 C7—C8 1.168 (9)
C1—O1 1.414 (7) C8—C9 1.433 (12)
C1—C6 1.502 (8) C9—C10 1.264 (16)
C1—H1A 0.9800 C9—H9 0.9300
O1—H1 0.8200 C10—H10A 0.9300
O3—C3 1.420 (5) C10—H10B 0.9300
O3—C11 1.422 (7) C11—C12 1.502 (9)
O4—C11 1.431 (6) C11—C13 1.521 (10)
O4—C4 1.436 (6) C12—H12A 0.9600
C3—C4 1.538 (7) C12—H12B 0.9600
C3—H3 0.9800 C12—H12C 0.9600
C4—C5 1.520 (7) C13—H13A 0.9600
C4—H4 0.9800 C13—H13B 0.9600
C5—C6 1.324 (8) C13—H13C 0.9600
O2—C2—C1 108.9 (4) C2—O2—H2A 109.5
O2—C2—C3 107.6 (5) C5—C6—C1 123.4 (5)
C1—C2—C3 109.1 (4) C5—C6—H6 118.3
O2—C2—H2 110.4 C1—C6—H6 118.3
C1—C2—H2 110.4 C8—C7—C5 177.7 (7)
C3—C2—H2 110.4 C7—C8—C9 176.9 (10)
O1—C1—C2 111.0 (4) C10—C9—C8 128.6 (13)
O1—C1—C6 107.3 (5) C10—C9—H9 115.7
C2—C1—C6 110.1 (4) C8—C9—H9 115.7
O1—C1—H1A 109.4 C9—C10—H10A 120.0
C2—C1—H1A 109.4 C9—C10—H10B 120.0
C6—C1—H1A 109.4 H10A—C10—H10B 120.0
C1—O1—H1 109.5 O3—C11—O4 106.5 (4)
C3—O3—C11 109.3 (4) O3—C11—C12 109.1 (5)
C11—O4—C4 103.6 (4) O4—C11—C12 108.5 (5)
O3—C3—C2 109.5 (4) O3—C11—C13 107.7 (6)
O3—C3—C4 103.5 (4) O4—C11—C13 112.4 (5)
C2—C3—C4 113.2 (4) C12—C11—C13 112.3 (6)
O3—C3—H3 110.1 C11—C12—H12A 109.5
C2—C3—H3 110.1 C11—C12—H12B 109.5
C4—C3—H3 110.1 H12A—C12—H12B 109.5
O4—C4—C5 108.0 (4) C11—C12—H12C 109.5
O4—C4—C3 104.9 (4) H12A—C12—H12C 109.5
C5—C4—C3 115.8 (4) H12B—C12—H12C 109.5
O4—C4—H4 109.3 C11—C13—H13A 109.5
C5—C4—H4 109.3 C11—C13—H13B 109.5
C3—C4—H4 109.3 H13A—C13—H13B 109.5
C6—C5—C7 122.4 (5) C11—C13—H13C 109.5
C6—C5—C4 119.6 (5) H13A—C13—H13C 109.5
C7—C5—C4 117.7 (5) H13B—C13—H13C 109.5
O2—C2—C1—O1 65.4 (6) C2—C3—C4—C5 −19.9 (6)
C3—C2—C1—O1 −177.4 (5) O4—C4—C5—C6 −127.6 (5)
O2—C2—C1—C6 −175.9 (5) C3—C4—C5—C6 −10.4 (7)
C3—C2—C1—C6 −58.7 (6) O4—C4—C5—C7 58.1 (6)
C11—O3—C3—C2 −122.7 (5) C3—C4—C5—C7 175.4 (5)
C11—O3—C3—C4 −1.7 (5) C7—C5—C6—C1 179.1 (5)
O2—C2—C3—O3 −72.8 (5) C4—C5—C6—C1 5.1 (9)
C1—C2—C3—O3 169.2 (4) O1—C1—C6—C5 151.3 (6)
O2—C2—C3—C4 172.3 (4) C2—C1—C6—C5 30.3 (8)
C1—C2—C3—C4 54.2 (6) C3—O3—C11—O4 22.5 (6)
C11—O4—C4—C5 156.9 (4) C3—O3—C11—C12 139.5 (5)
C11—O4—C4—C3 32.8 (5) C3—O3—C11—C13 −98.3 (5)
O3—C3—C4—O4 −19.4 (5) C4—O4—C11—O3 −34.5 (5)
C2—C3—C4—O4 99.0 (5) C4—O4—C11—C12 −151.9 (6)
O3—C3—C4—C5 −138.4 (4) C4—O4—C11—C13 83.2 (6)

(3aS,4R,5S,7aR)-7-(But-3-en-1-yn-1-yl)-2,2-dimethyl-3a,4,5,7a-tetrahydro-2H-1,3-benzodioxole-4,5-diol . Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
O1—H1···O1i 0.82 2.00 2.803 (3) 167
O2—H2A···O3ii 0.82 2.19 2.995 (6) 168

Symmetry codes: (i) −x+1/2, y−1/2, −z+1; (ii) −x+1, y, −z+1.

Funding Statement

Funding for this research was provided by: Agencia Nacional de Investigación e Innovación (grant No. FCE_1_2017_1_135581).

References

  1. Bourhis, L. J., Dolomanov, O. V., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2015). Acta Cryst. A71, 59–75. [DOI] [PMC free article] [PubMed]
  2. Bruker (2018). APEX3 and SAINT. Bruker AXS Inc., Madison, Wisonsin, USA.
  3. Buckler, J. N., Taher, E. S., Fraser, N. J., Willis, A. C., Carr, P. D., Jackson, C. J. & Banwell, M. G. (2017). J. Org. Chem.82, 15, 7869–7886. [DOI] [PubMed]
  4. Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc.97, 1354–1358.
  5. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst.42, 339–341.
  6. Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
  7. Hookins, D. R., Burns, A. R. & Taylor, R. J. K. (2011). Eur. J. Org. Chem. pp. 451–454.
  8. Hübschle, C. B., Sheldrick, G. M. & Dittrich, B. (2011). J. Appl. Cryst.44, 1281–1284. [DOI] [PMC free article] [PubMed]
  9. Jiang, M.-Y., Li, Y., Wang, F. & Liu, J.-K. (2011). Phytochemistry, 72, 923–928. [DOI] [PubMed]
  10. Jiang, M.-Y., Zhang, L., Liu, R., Dong, Z.-J. & Liu, J.-K. (2009). J. Nat. Prod.72, 1405–1409. [DOI] [PubMed]
  11. Kim, H.-J., Vinale, F., Ghisalberti, E. L., Worth, C. M., Sivasithamparam, K., Skelton, B. W. & White, A. H. (2006). Phytochemistry, 67, 2277–2280. [DOI] [PubMed]
  12. Krause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst.48, 3–10. [DOI] [PMC free article] [PubMed]
  13. Macías, M. A., Suescun, L., Pandolfi, E., Schapiro, V., Tibhe, G. D. & Mombrú, Á. W. (2015). Acta Cryst. E71, 1013–1016. [DOI] [PMC free article] [PubMed]
  14. Nagata, T., Ando, Y. & Hirota, A. (1992). Biosci. Biotechnol. Biochem.56, 810–811. [DOI] [PubMed]
  15. Pandolfi, E., Schapiro, V., Heguaburu, V. & Labora, M. (2013). Curr. Org. Synth.10, 2–42.
  16. Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259. [DOI] [PMC free article] [PubMed]
  17. Peixoto de Abreu Lima, A., Suescun, L., Pandolfi, E. & Schapiro, V. (2019). New J. Chem.43, 3653–3655.
  18. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  19. Taher, E. S., Guest, P., Benton, A., Ma, X., Banwell, M. G., Willis, A. C., Seiser, T., Newton, T. W. & Hutzler, J. (2017). J. Org. Chem.82, 1, 211–233. [DOI] [PubMed]
  20. Tibhe, G. D., Macías, M. A., Schapiro, V., Suescun, L. & Pandolfi, E. (2018). Molecules, 23, 1653. [DOI] [PMC free article] [PubMed]
  21. Vila, M. A., Brovetto, M., Gamenara, D., Bracco, P., Zinola, G., Seoane, G., Rodríguez, S. & Carrera, I. (2013). J. Mol. Catal. B Enzym.96, 14–20.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989024009733/ee2008sup1.cif

e-80-01165-sup1.cif (320.1KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989024009733/ee2008Isup2.hkl

e-80-01165-Isup2.hkl (210.4KB, hkl)
e-80-01165-Isup3.cml (5.2KB, cml)

Supporting information file. DOI: 10.1107/S2056989024009733/ee2008Isup3.cml

CCDC reference: 2389407

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES